Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon
Tech Nation: My Creations Have Upgrade Panels
Chapter 128

Four Major Gene Editor Technology Lines

1,292 words 4 min read 1 view 2mo ago Source ​
Skip to the end of the chapter
Prev
Next

Therefore, although the inventors' names are listed on the patent, the ownership and decision-making power of the patent actually belong to the Max Planck Institute according to the original contract.

In terms of profit, their actual profit share is not high, only a small portion compared to the Max Planck Institute.

This is the current state of the global scientific research field, and it is a helpless reality for researchers worldwide. It can only be said that researchers can make a small profit, but investors never lose money.

Moreover, if the two were to leave the Max Planck Institute at the same time, the Max Planck Institute's CRISPR/Cas9 Gene Editing Technology research and development would undoubtedly come to a complete standstill.

In this situation, they simply want to leave, but whether the Max Planck Institute is willing to let them go is another matter entirely.

"The two doctors don't need to worry about the Max Planck Institute's issues. Next, I will spend money to purchase a license or buy out the CRISPR/Cas9 Gene Editing Technology patent."

This funding would definitely tempt the Max Planck Institute. As for whether the Max Planck Institute would release the person, it was simply a matter of whether there was enough money.

In short, our Xingtu Gene Company has money. As long as you're interested, leave the rest to us!

At this point, Lin Feng still needed to purchase the Max Planck Institute's technology patent licenses for CRISPR/Cas9 Gene Editing Technology, or even buy out the licenses.

This is because the European and American Empire made drastically different decisions regarding the ownership of CRISPR/Cas9 Gene Editing Technology patents in the previous era.

The European Patent Office has determined that the patent for CRISPR/Cas9 Gene Editing Technology belongs to the Max Planck Institute.

Meanwhile, the American Empire Patent Office determined that the CRISPR/Cas9 Gene Editing Technology patent belongs to the Broad Institute at the American Empire Harvard University.

Under such circumstances, just in case, Xingtu Gene Company had no choice but to spend money twice to purchase technology patent licenses or buy out licenses from both parties.

Therefore, whether in Europe or the American Empire, Xingtu Gene Company' gene therapy products based on CRISPR/Cas9 Gene Editing Technology are legal and compliant.

Of course, this legality and compliance is probably only feasible overseas, but not in China, because according to the history of the previous life, in 2018...

Following the creation of the world's first gene-edited babies by a professor named He Jian in Great Xia who used CRISPR/Cas9 Gene Editing Technology, babies were born with natural resistance to AIDS.

Under immense public pressure, the Great Xia enacted a new law in less than two years, explicitly stating that gene-edited and cloned human embryos could not be implanted into humans or animals.

Or, if gene-edited or cloned animal embryos are implanted into the human body, and the circumstances are serious, the offender shall be sentenced to fixed-term imprisonment of not more than three years or criminal detention, and shall also be fined.

Those whose circumstances are particularly serious shall be sentenced to fixed-term imprisonment of not less than three years but not more than seven years and shall also be fined.

Under such circumstances, even if Xingtu Gene Company develops gene therapy products, whether they are legal and compliant is still unknown.

Although the gene therapy products at that time certainly had nothing to do with embryos, but were directly implanted into the bodies of adults or infants.

Their offspring are also very likely to avoid hereditary diseases such as AIDS, Thalassemia, phenylketonuria, and hemophilia due to genetic mechanisms.

However, the genes altered by CRISPR/Cas9 Gene Editing Technology are ultimately permanent changes; once changed, they are permanently altered.

This kind of gene modification is extremely dangerous, and no one knows what hidden dangers it may pose in the future.

After all, it took billions of years for Earth to evolve from the earliest single-celled organisms to the emergence of highly intelligent life like humans, going through countless trials and tribulations before finally giving rise to a highly intelligent species like humans.

Under such circumstances, human genes are currently at their most stable. To arbitrarily modify genes at this point and disrupt the success of billions of years of evolution would naturally involve enormous risks.

Therefore, it is not easy for gene therapy products to be launched on the market, after all, no one knows what unknown risks may exist.

Even if this hidden danger doesn't surface now, but only after decades or centuries, no one would dare to easily approve its listing.

Even if there are no problems now, when the hidden dangers erupt decades or centuries later, they will be condemned to death in history books.

Therefore, even if a corresponding gene product is developed, it is not an easy task for this product to be legally and compliantly launched within the Great Xia region.

It can only be said that within the Great Xia region, there is a high probability that such gene therapy products will not be able to be marketed, unless their safety can be clearly proven.

"In that case, I agree."

Dr. Doudna was the first to agree.

After she finished speaking, she turned her gaze to her partner Dr. Charpentier.

"In that case, I agree."

Dr. Charpentier shrugged and agreed.

"Then I wish us a pleasant cooperation."

Lin Feng cupped his hands and said with a smile.

At this point, he was confident of victory over the two PhDs, even though their research achievements seemed significant and attracted considerable attention.

However, current Gene Editing Technology is only a cutting-edge scientific research technology, and it is not something that can be seen or achieved in a few years or ten years.

Moreover, current Gene Editing Technology is not limited to CRISPR/Cas9 Gene Editing Technology alone.

In fact, several other major research lines also exist simultaneously, namely the Homologous Recombination Technology Development Line, the zinc finger nuclease Gene Editing Technology development line, and the transcription activation-like effector nuclease technology development line...

Furthermore, barring unforeseen circumstances, a new Gene Editing Technology development pipeline will emerge next year, and in the coming years, Prime Editing Technology Line and Base Editing Technology Development Line will also appear.

Among these, CRISPR/Cas9 Gene Editing Technology is just one of the four major gene editor technology lines currently in use.

The reason why CRISPR/Cas9 Gene Editing Technology was so famous in the past was because it had the lowest research threshold.

Finally, the Broad Institute announced that all patents related to their CRISPR/Cas9 Gene Editing Technology will be permanently free in the research field, while charging will apply to the commercial sector.

This free and open-source model has successfully attracted countless gene experts from around the world to devote themselves to the research and development of CRISPR/Cas9 Gene Editing Technology.

Subsequently, with the strength of a large workforce, the CRISPR/Cas9 Gene Editing Technology route among the four major routes developed at a remarkably rapid pace, acquiring 15,000 related patents in less than ten years.

Under these circumstances, it would be somewhat difficult for Xingtu Gene Company to poach talent from the Max Planck Institute, but it's not actually that difficult; it's simply a matter of money.

But money isn't an issue for Lin Feng, so this isn't a problem.

Of course, the reason Lin Feng was willing to spend so much to recruit these two PhDs was not only because he valued their talent, but also because he wanted to build trust for his future Fake-to-Real Plan.

After all, they are the inventors of CRISPR/Cas9 Gene Editing Technology. With their participation, Lin Feng claims that they also participated in the research and development of Gene Enhancement Potion and made a huge contribution.

This fake Gene Enhancement Potion is inherently somewhat trustworthy, and with a huge number of viewers, it's not impossible that it could become real despite being fake!

Of course, Lin Feng actually preferred to recruit Zhang Feng, the super genius in the field of genetics from the Broad Institute.

Unfortunately, Zhang Feng is currently enjoying a period of great success.

Because Zhang Feng currently has access to both research funding and support personnel at the Broad Institute.

End of Chapter
Prev
NovelSummaries
Next

Explore the wiki

Lin Feng
Great Xia
American Empire

Comments

No comments yet.
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS